WebMar 25, 2015 · Cancer-associated isocitrate dehydrogenase (IDH) 1 and 2 mutations gain a new activity of reducing α-KG to produce D-2-hydroxyglutarate (D-2-HG), which is proposed to function as an... WebD2HG is produced via somatic gain-of-function mutations in IDH1/2 in cancer cells in the TME and is now recognized as an immunosup- pressive mediator.11Previous studies have revealed that D2HG treat- ment impaired activated T cell migration, proliferation, and cytokine secretion.12In vivo experiments showed that mice bearing mutational IDH1 …
Elevated D-2-hydroxyglutarate during colitis drives …
WebJan 16, 2024 · The colonic expression of D2HGDH is decreased in ulcerative colitis (UC) patients at baseline who progress to cancer. Hypoxia-inducible factor (Hif)-1α is a key … WebApr 4, 2015 · D2HGDH overexpression reduces D-2-HG level in IDH -mutated cancer cells Previous studies using cell permeable D-2-HG analogs or mutant IDH inhibitors have the limitation of possible nonspecific effects associated with all pharmacological agents. list of household services
Expression of PCDHGB2 in cancer - Summary - Protein Atlas
WebConversely, the D2HGDH mutants that we find in diffuse large B-cell lymphoma are enzymatically inert. D2-HG is a low-abundance metabolite, but we show that it can meaningfully elevate α-KG levels by positively modulating mitochondrial IDH activity and inducing IDH2 expression. WebAug 19, 2024 · Phenotypic Information for D2HGDH(metabolism pathway, cancer, disease, phenome) Cancer Description: Cancer : CGAP: D2HGDH : Familial Cancer Database: D2HGDH * This gene is included in those cancer gene databases.. Oncogene 1. Tumor Suppressor gene 2. Cancer Gene Census 3. CancerGenes 4. WebJan 7, 2024 · Our data link D2HGDH to cancer and describe an additional role for the enzyme: the regulation of IDH2 activity and a-KG-mediated epigenetic remodelling. These data further expose the intricacies ... imatu facebook